{"id":456561,"date":"2021-03-11T21:03:16","date_gmt":"2021-03-12T02:03:16","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=456561"},"modified":"2021-03-11T21:03:16","modified_gmt":"2021-03-12T02:03:16","slug":"sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/","title":{"rendered":"SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm"},"content":{"rendered":"

<\/p>\n

SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm<\/b><\/p>\n

NEW YORK–(BUSINESS WIRE<\/a>)–
\nBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) on behalf of Sonoma stockholders. Our investigation concerns whether Sonoma has violated the federal securities laws and\/or engaged in other unlawful business practices.\n<\/p>\n

\nClick here<\/a> to participate in the action.\n<\/p>\n

\nSonoma filed an 8-K with the SEC on November 17, 2020. The filing announced that the Company\u2019s \u201cunaudited condensed consolidated interim financial statements for the quarter ended June 30, 2020 should no longer be relied upon.\u201d The Company added that the financial statements \u201ccontained material errors\u201d and that \u201cthe Company will need to restate them.\u201d\n<\/p>\n

\nBased on these facts, the Company\u2019s shares fell by more than 14% on the next trading day, to close at $6.82 per share on November 18, 2020.\n<\/p>\n

\nIf you purchased or otherwise acquired Sonoma shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker, Melissa Fortunato, or Marion Passmore by email at investigations@bespc.com<\/a>, or telephone at (212) 355-4648, or by filling out this contact form<\/a>. There is no cost or obligation to you.\n<\/p>\n

About Bragar Eagel & Squire, P.C.:<\/b><\/p>\n

\nBragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com<\/a>. Attorney advertising. Prior results do not guarantee similar outcomes.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210311005891\/en\/<\/a><\/span><\/p>\n

\nBragar Eagel & Squire, P.C.
\n
Brandon Walker, Esq.
\n
Melissa Fortunato, Esq.
\n
Marion Passmore, Esq.
\n
(212) 355-4648
\n
investigations@bespc.com
\n<\/a>
www.bespc.com<\/a><\/p>\n

KEYWORDS:<\/b> New York United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm NEW YORK–(BUSINESS WIRE)– Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) on behalf of Sonoma stockholders. Our investigation concerns whether Sonoma has violated the federal securities laws and\/or engaged in other unlawful business practices. Click here to participate in the action. Sonoma filed an 8-K with the SEC on November 17, 2020. The filing announced that the Company\u2019s \u201cunaudited condensed consolidated interim financial statements for the quarter ended June 30, 2020 should no longer be relied upon.\u201d The Company added that … <\/p>\n

Continue reading “SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-456561","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm NEW YORK–(BUSINESS WIRE)– Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) on behalf of Sonoma stockholders. Our investigation concerns whether Sonoma has violated the federal securities laws and\/or engaged in other unlawful business practices. Click here to participate in the action. Sonoma filed an 8-K with the SEC on November 17, 2020. The filing announced that the Company\u2019s \u201cunaudited condensed consolidated interim financial statements for the quarter ended June 30, 2020 should no longer be relied upon.\u201d The Company added that … Continue reading "SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-12T02:03:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210311005891r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm\",\"datePublished\":\"2021-03-12T02:03:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\\\/\"},\"wordCount\":382,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210311005891r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\\\/\",\"name\":\"SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210311005891r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-03-12T02:03:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210311005891r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210311005891r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/","og_locale":"en_US","og_type":"article","og_title":"SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm - Market Newsdesk","og_description":"SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm NEW YORK–(BUSINESS WIRE)– Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) on behalf of Sonoma stockholders. Our investigation concerns whether Sonoma has violated the federal securities laws and\/or engaged in other unlawful business practices. Click here to participate in the action. Sonoma filed an 8-K with the SEC on November 17, 2020. The filing announced that the Company\u2019s \u201cunaudited condensed consolidated interim financial statements for the quarter ended June 30, 2020 should no longer be relied upon.\u201d The Company added that … Continue reading \"SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-12T02:03:16+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210311005891r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm","datePublished":"2021-03-12T02:03:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/"},"wordCount":382,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210311005891r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/","name":"SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210311005891r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-03-12T02:03:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210311005891r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210311005891r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonoma-pharmaceuticals-alert-bragar-eagel-squire-p-c-is-investigating-sonoma-pharmaceuticals-inc-on-behalf-of-sonoma-stockholders-and-encourages-investors-to-contact-the-firm-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456561","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=456561"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456561\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=456561"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=456561"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=456561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}